References for Chapter II
Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: The Malmö Mammographic Screening Trial. BMJ. 1988; 297(6654):943-8. PubMed | PMC free article.
Banta HD, Luce BR. Health Care Technology and Its Assessment: An International Perspective. New York, NY: Oxford University Press; 1993.
Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19(8):787-805.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95. PubMed
Bleichrodt H, Johannesson M. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. J Health Econ. 1997;16(2):155-75. PubMed
Breitkreutz I, Anderson KC. Thalidomide in multiple myeloma--clinical trials and aspects of drug metabolism and toxicity. Expert Opin Drug Metab Toxicol. 2008;4(7):973-85. PubMed
Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628-36. PubMed | PMC free article
Buxton MJ. Problems in the economic appraisal of new health technology: the evaluation of heart transplants in the UK. In Drummond MF, ed. Economic Appraisal of Health Technology in the European Community. Oxford, England. Oxford Medical Publications, 1987.
Chou R, Croswell JM, Dana T, et al. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011 Dec 6;155(11):762-71. PubMed | Publisher free article
Coleman RE, Briner WH, Siegel BA. Clinical PET scanning. A short-lived orphan. Int J Technol Assess Health Care. 1992;8(4):610-22. PubMed
Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000;17(1):13-35. PubMed
Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation. 1990;82(4):1106-16. PubMed
de Bruin AF, de Witte LP, Stevens F, Diederiks JP. Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med. 1992;35(8):1003-14. PubMed
Doctor JN, Bleichrodt H, Lin HJ. Health utility bias: a systematic review and meta-analytic evaluation. Med Decis Making. 2010;30(1):58-67. PubMed
Dolan P. Utilitarianism and the measurement and aggregation of quality-adjusted life years. Health Care Anal. 2001;9(1):65-76. PubMed
Doll H.A, Black NA, Flood AB, McPherson K. Criterion validation of the Nottingham health profile: patient views of surgery for benign prostatic hypertrophy. Soc Sci Med. 1993;37(1):11522. PubMed
Duthie K, Bond K. Improving ethics analysis in health technology assessment. Int J Technol Assess Health Care 2011;27(1):64-70. PubMed
Enkin M, Nelison J, Crowther C, Duley L, et al. A Guide to Effective Care in Pregnancy and Childbirth. 3rd ed. New York, NY: Oxford University Press; 2000.
EUnetHTA (European Network for Health Technology Assessment). HTA Core Model for Medical and Surgical Interventions Version 1.0 Work Package 4. The HTA Core Model. December 2008. Publisher free publication
EUnetHTA. HTA Core Model® Online. National Institute for Health and Welfare. Helsinki; 2013. Accessed June 18, 2014 at: https://meka.thl.fi/htacore/Default.aspx.
FDA Center for Drug Evaluation and Research. Memorandum to the File: BLA 125085 Avastin (bevacizumab). Regulatory Decision to Withdraw Avastin (bevacizumab) Firstline Metastatic Breast Cancer Indication December 15, 2010. Accessed Sept. 1, 2011 at: http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM237171.pdf.
Feeny D, Guyatt G, Tugwell P, eds. Health care Technology: Effectiveness, Efficiency, and Public Policy. Montreal, Canada: Institute for Research on Public Policy; 1986.
Feeny D, Spritzer K, Hays RD, Liu H, et al. Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients. Med Decis Making. 2012;32(2):273-86. PubMed | PMC free article
Fineberg HV, Bauman R, Sosman M. Computerized cranial tomography: effect on diagnostic and therapeutic plans. JAMA. 1977;238(3):224-7. PubMed
Fletcher SW, Colditz GA. Failure of estrogen plus progestin therapy for prevention. JAMA. 2002;288(3):366-8. PubMed
Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med. 1992;92(2):121-94. PubMed
Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan. 2001;16(3):326-31. PubMed | PMC free article
Frosch DL, Kaplan RM, Ganiats TG, Groessl EJ, Sieber WJ, Weisman MH. Validity of self-administered quality of well-being scale in musculoskeletal disease. Arthritis Rheum. 2004;51(1):28-33. PubMed | Publisher free article
Fryback DG, Dunham NC, Palta M, Hanmer J, et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care. 2007;45(12):1162-70. PubMed | PMC free article
Fu TC, Westergaard RP, Lau B, Celentano DD, Vlahov D, Mehta SH, Kirk GD. Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users. AIDS. 2012;26(18):2383-91. Accessed June 18, 2014 at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678983\. PubMed
Gelijns A, Rosenberg N. The dynamics of technological change in medicine. Health Aff (Millwood). 1994;13(3):28-46. PubMed | Publisher free article
George SM. Millions of missing girls: from fetal sexing to high technology sex selection in India. Prenat Diagn. 2006 Jul;26(7):604-9. PubMed
Gibson JL, Martin DK, Singer PA. Priority setting for new technologies in medicine: a transdisciplinary study. BMC Health Serv Res. 2002;2(1):14. PubMed | PMC free article
Glasziou P. What is EBM? Evid Based Med. 2011;16(5):129-30. PubMed
Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health. Annu Rev Public Health. 2002;23:115-34. PubMed
Goodman C. The moving target problem and other lessons from percutaneous transluminal coronary angioplasty. In: A Szczepura, Kankaanpää J. Assessment of Health Care Technologies: Case Studies, Key Concepts and Strategic Issues. New York, NY: John Wiley & Sons; 1996:29-65.
Goodman CS. Technology assessment in healthcare: a means for pursuing the goals of biomedical engineering. Med Biolog Eng Comput. 1993;31(1):HTA3-10. PubMed
Green ED, Guyer MS; National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470(7333):204-13. PubMed
Gregorian RS, Golden KA, Bahce A, Goodman C, et al. Antidepressant-induced sexual dysfunction. Ann Pharmacother. 2002;36(10):1577-89. PubMed
Grimes DA. Technology follies: the uncritical acceptance of medical innovation. JAMA. 1993;269(23):3030-3. PubMed
Guyatt G, Rennie D, Meade MO, Cook DJ. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 2nd Edition. New York: McGraw-Hill, 2008.
Hackam DG, Eikelboom JW. Antithrombotic treatment for peripheral arterial disease. Heart. 2007;93(3):303-8. PubMed | PMC free article
Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force. A review of the process. Am J Prev Med. 2001;20(3S):21-35. PubMed
Hayes JH, Barry MJ. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA. 2014;311(11):1143-9. PubMed
Heitman E. Ethical issues in technology assessment. Conceptual categories and procedural considerations. Int J Technol Assess Health Care. 1998;14(3):544-66. PubMed
Hilborne LH, Leape LL, Kahan JP, Park RE, et al. Percutaneous Transluminal Coronary Angioplasty: A Literature Review of Ratings of Appropriateness and Necessity. Santa Monica, Ca: RAND; 1991. Publisher free publication
Hollis A, Ahmed Z. Preserving antibiotics, rationally. N Engl J Med. 2013;369(26):2474-6. PubMed | Publisher free article]
Hsueh IP, Lin JH, Jeng JS, Hsieh CL. Comparison of the psychometric characteristics of the functional independence measure, 5 item Barthel index, and 10 item Barthel index in patients with stroke. J Neurol Neurosurg Psychiatry. 2002;73(2):188-90. PubMed | PMC free article
Hudson KL. Genomics, health care, and society. N Engl J Med. 2011;365(11):1033-41. PubMed | Publisher free article
Huesch MD. One and done? Equality of opportunity and repeated access to scarce, indivisible medical resources. BMC Med Ethics. 2012;13:11. PubMed | PMC free article
Institute of Medicine. Assessing Medical Technologies. Washington, DC: National Academy Press; 1985. Publisher free book]
Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011. Publisher free book
The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273(8):625-32. PubMed
Jenkinson C, Fitzpatrick R, Argyle M. The Nottingham Health Profile: an analysis of its sensitivity to differentiating illness groups. Soc Sci Med. 1988;27(12):1411-4. PubMed
Johannesson M, Pliskin JS, Weinstein MC. Are healthy-years equivalents an improvement over quality-adjusted life years? Med Dec Making. 1993;13(4):281-6.PubMed
Jüni P, Nartey L, Reichenbach S, et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364(9450):2021-9. PubMed
Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147(4):832-8. PubMed
Juniper EF, Svensson K, Mörk AC, Ståhl E. Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older. Health Qual Life Outcomes. 2005;3:58. Pubmed | PMC free article.
Kahan JP, Bernstein SJ, Leape LL, Hilborne LH, Park RE, Parker L, Kamberg CJ, Brook RH. Measuring the necessity of medical procedures. Med Care. 1994;32(4):357-65. PubMed
Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The Quality of Well-being Scale: applications in AIDS, cystic fibrosis, and arthritis. Med Care. 1989; 27(3 Suppl): S27-43. PubMed
Kaplan RM, Ganiats TG, Sieber WJ, Anderson JP. The Quality of Well-Being Scale: critical similarities and differences with SF-36. Int J Qual Health Care. 1998;10(6):509-20. PubMed | Publisher free article
Kaplan RM, Tally S, Hays RD, Feeny D, Ganiats TG, et al. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J Clin Epidemiol 2011;64(5):497-506. PubMed | PMC free article
Kembabazi A, Bajunirwe F, Hunt PW, Martin JN, et al. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS One. 2013;8(7):e69634. PubMed | PMC free article
Kling J. From hypertension to angina to Viagra. Mod. Drug Discov. 1998;1(2):31-8.
Kuperman GJ, Blair JS, Franck RA, Devaraj S, Low AF; NHIN Trial Implementations Core Services Content Working Group. Developing data content specifications for the nationwide health information network trial implementations. J Am Med Inform Assoc. 2010;17(1):6-12. PubMed | PMC free article
The Lewin Group. Outlook for Medical Technology Innovation. Report 4: The Impact of Regulation and Market Dynamics on Innovation. Washington, DC: AdvaMed; 2001.
Lalezari JP, Henry K, O’Hearn M, et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med. 2003;348(22):2175-85. PubMed | Publisher free article
Lampe K, Mäkelä M, Garrido MV, et al. ; European network for Health Technology Assessment (EUnetHTA). The HTA core model: a novel method for producing and reporting health technology assessments. Int J Technol Assess Health Care. 2009;25 Suppl 2:9-20. PubMed
Lauritsen KJ, Nguyen T. Combination products regulation at the FDA. Clin Pharmacol Ther. 2009;85(5):468-70. PubMed
Lechler RI, Sykes M, Thomson AW, Turka LA. Organ transplantation--how much of the promise has been realized? Nat Med. 2005;11(6):605-13. PubMed
Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(3):192-9. PubMed
Linacre JM, Heinemann AW, Wright BD, Granger CV, Hamilton BB. The structure and stability of the Functional Independence Measure. Arch Phys Med Rehab. 1994;75(2):127-32. PubMed
Malyszko J, Muntner P, Rysz J, Banach M. Blood pressure levels and stroke: J-curve phenomenon? Curr Hypertens Rep. 2013;15(6):575-81. PubMed | PMC free article
Martin ML, Patrick DL, Gandra SR, Bennett AV, et al. Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia. Qual Life Res 2011;20(6):889-901. PubMed
Massa T. An industry perspective: challenges in the development and regulation of drug-device combination products. In Hanna K, Manning FJ, Bouxsein P, Pope A, eds. Innovation and Invention in Medical Devices. Workshop Summary. Institute of Medicine. Washington, DC: National Academy Press; 2001:16-20. Publisher free book
McKinlay JB. From “promising report” to “standard procedure”: seven stages in the career of a medical innovation. Milbank Memorial Fund Quarterly. 1981;59(3):374-411. PubMed
Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of revised and expanded arthritis impact measurement scales health status questionnaire. Arthritis Rheum. 1992;35(1):1-10. PubMed
Mello MM, Brennan TA. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. Health Aff (Millwood). 2001;20(5):101-17. PubMed | Publisher free article
Moss AH. Ethical principles and processes guiding dialysis decision-making. Clin J Am Soc Nephrol. 2011;6(9):2313-7. PubMed] | Publisher free article
Mowatt G, Bower DJ, Brebner JA, Cairns JA, et al. When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies. Health Technol Assess. 1997;1(14). PubMed | Publisher free article
Mullahy J. Live long, live well: quantifying the health of heterogeneous populations. Health Econ. 2001;10(5):429-40. PubMed
Newcomer LN. Defining experimental therapy − a third party payer's dilemma. N Engl J Med. 1990;323(24):1702-4. PubMed
Nie JB. Non-medical sex-selective abortion in China: ethical and public policy issues in the context of 40 million missing females. Br Med Bull. 2011;98:7-20. PubMed | Publisher free article
Nord E, Enge AU, Gundersen V. QALYs: is the value of treatment proportional to the size of the health gain? Health Econ. 2010;19(5):596-607. PubMed
Oldridge N, Furlong W, Perkins A, Feeny D, Torrance GW. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter? Eur J Cardiovasc Prev Rehabil. 2008;15(5):608-15. PubMed
Passamani E. Clinical trials: are they ethical? N Engl J Med. 1991;324(22):1589-92. PubMed
Patrick DL, Martin ML, Bushnell DM, Marquis P, Andrejasich CM, Buesching DP: Cultural adaptation of a quality-of-life measure for urinary incontinence. Eur Urol. 1999;36(5):427-35. PubMed
Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA. Measuring preferences for health states worse than death. Med Dec Making. 1994;14(1):9-18. PubMed
Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670-5. PubMed | PMC free article
Peters WP, Rosner GL, Vredenburgh JJ, et al. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. J Clin Oncol. 2005;23(10):2191-200. PubMed
Post MW, Gerritsen J, Diederikst JP, DeWittet LP. Measuring health status of people who are wheelchair-dependent: validity of the Sickness Impact Profile 68 and the Nottingham Health Profile. Disabil Rehabil. 2001;23(6):245-53. PubMed
Potter BK, Avard D, Graham ID, et al. Guidance for considering ethical, legal, and social issues in health technology assessment: application to genetic screening. Int J Technol Assess Health Care. 2008;24(4):412-22. PubMed
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337-43. PubMed
Reiser SJ. Criteria for standard versus experimental therapy. Health Aff (Millwood). 1994;13(3):127-36. PubMed Publisher free article
Rettig RA, Jacobson PD, Farquhar CM, Aubry WM. False Hope: Bone Marrow Transplantation for Breast Cancer. New York: Oxford University Press; 2007.
Rettig RA, Levinsky NG, eds. Kidney Failure and the Federal Government. Washington, DC: National Academy Press; 1991. PubMed | Publisher free book
Reuzel RP, van der Wilt GJ, ten Have HA, de Vries Robbe PF. Interactive technology assessment and wide reflective equilibrium. J Med Philos. 2001;26(3):245-61. PubMed
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33. PubMed
Saarni SI, Braunack-Mayer A, Hofmann B, van der Wilt GJ. Different methods for ethical analysis in health technology assessment: An empirical study. Int J Technol Assess Health Care 2011;27(4):305-12. PubMed
Saban KL, Stroupe KT, Bryant FB, Reda DJ, et al. Comparison of health-related quality of life measures for chronic renal failure: quality of well-being scale, short-form-6D, and the kidney disease quality of life instrument. Qual Life Res. 2008;17(8):1103-15.PubMed
Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine. New York, NY: Churchill Livingstone, 1997.
Sadock J, Tolman ED. Capital equipment budgeting: changing an art to a science. J Healthc Resour Manag. 1997;15(8):16-21. PubMed
Sassi F. Setting priorities for the evaluation of health interventions: when theory does not meet practice. Health Policy. 2003;63(2):141-54. PubMed
Schwappach DL. Resource allocation, social values and the QALY: a review of the debate and empirical evidence. Health Expect. 2002;5(3):210-22. PubMed
Singer SJ, Bergthold LA. Prospects for improved decision making about medical necessity. Health Aff (Millwood). 2001;20(1):200-6. PubMed | Publisher free article
Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, et al. Reproducibility of the STARD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies. BMC Med Res Methodol. 2006;6:12. PubMed | PMC free article
Söderlin MK, Kautiainen H, Skogh T, Leirisalo-Repo M. Quality of life and economic burden of illness in very early arthritis. A population based study in southern Sweden. J Rheumatol 2004;31(9):1717-22. PubMed
Soto-Gutierrez A, Wertheim JA, Ott HC, Gilbert TW. Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest. 2012;122(11):3817-23. PubMed | PMC free article
Sox H, Stern S, Owens D, Abrams HL. Assessment of Diagnostic Technology in Health Care: Rationale, Methods, Problems, and Directions. Institute of Medicine. Washington, DC: National Academy Press; 1989.
Srinivas SV, Deyo RA, Berger ZD. Application of "less is more" to low back pain. Arch Intern Med. 2012;172(13):1016-20. PubMed
Stamuli E. Health outcomes in economic evaluation: who should value health? Br Med Bull. 2011;97:197-210. PubMed
Straus SE, Richardson WS, Glasziou P, Haynes RB. Evidence-Based Medicine: How to Practice and Teach It. 4th ed. New York, NY: Churchill Livingstone Elsevier, 2011.
Taylor KS. Hospital tech assessment teams field requests − and politics. Hosp Health Netw. 1994;68(16):58. PubMed
Thiele AT, Leier B. Towards an ethical policy for the prevention of fetal sex selection in Canada. J Obstet Gynaecol Can. 2010 Jan;32(1):54-7. PubMed
Thornbury JR, Fryback DG. Technology assessment − An American view. Eur J Radiol. 1992;14(2):147-56. PubMed
Toh S, Hernández-Díaz S, Logan R, Rossouw JE, Hernán MA. Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med. 2010;152(4):211-7. PubMed | PMC free article
Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5(4):559-75. PubMed
Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis. 2004;38(8):1167-74. PubMed | Publisher free article
US Congress, House of Representatives. Committee on Science and Astronautics. Technology Assessment. Statement of Emilio Q. Daddario, Chairman, Subcommittee on Science Research and Development. 90th Cong., 1st sess., Washington, DC; 1967.
US Department of Health and Human Services, Agency for Health Care Policy and Research. Extracranial-Intracranial Bypass to Reduce the Risk of Ischemic Stroke. Health Technology Assessment Reports. No. 6. Rockville, Md; 1990. Bookshelf free publication
US Department of Health and Human Services, Agency for Health Care Policy and Research. Intermittent Positive Pressure Breathing: Old Technologies Rarely Die. Rockville, MD; 1993. Publisher free publication
US Food and Drug Administration. Guidance for Industry and FDA Staff. Pharmacogenetic Tests and Genetic Tests for Heritable Markers. June 19, 2007. Accessed June 18, 2014 at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071075.pdf
Van der Wilt GJ, Reuzel R, Banta HD. The ethics of assessing health technologies. Theor Med Bioeth. 2000;21(1):103-15. PubMed
Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP: Quality of life in persons with urinary incontinence: development of a new measure. Urology 1996;47(1):67-72. PubMed
Ware JE Jr., Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36): I. conceptual framework and item selection. Med Care. 1992;30(6):47383. PubMed
Weinstein MC, Skinner JA. Comparative effectiveness and health care spending--implications for reform. N Engl J Med. 2010;362(5):460-5. PubMed | PMC free article
Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull 2010;96:5-21. PubMed | Publisher free article
Whiting PF, Rutjes AW, Westwood ME, et al. ; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36. PubMed
Yang H. Let genomics go global. The World in 2013. Economist. Nov. 21, 2012. Accessed November 18, 2014 at: http://www.economist.com/news/21566443-life-sciences-are-ready-revolution-it-will-require-collaboration-many-fronts-says-yang.
Yoshida EM. Selecting candidates for liver transplantation: a medical ethics perspective on the microallocation of a scarce and rationed resource. Can J Gastroenterol. 1998;12(3):209-15. PubMed
Zhou S, Wang F, Hsieh TC, Wu JM, Wu E. Thalidomide-a notorious sedative to a wonder anticancer drug. Curr Med Chem. 2013;20(33):4102-8. PubMed | PMC free article